Nyxoah (Nasdaq:NYXH) announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.

NanoVibronix (Nasdaq:NAOV) today announced that it intends to effect a reverse stock split of its common stock.

Gentuity announced that it entered into an agreement with GE HealthCare to collaborate on commercial activities for imaging ...